We sought to examine the extent to which physicians recognize H. pylori as a causal agent in peptic ulcer disease or as a potential cofactor in other gastrointestinal diseases, and to observe how this knowledge has influenced diagnostic and therapeutic practices.
We used a national mail survey in the U.S. between February and May of 1996, querying 5994 U.S. physicians (family/general practitioners [FPs], internists [IMs], and gastroenterologists) selected at random from three different membership databases of professional associations.
The response rate was 52%. More than 95% of physicians who treat symptoms empirically would prescribe acid suppressant therapy rather than anti-H. pylori therapy.
Between 43% and 66% of physicians, varying in frequency by medical specialty, would treat the infection in H. pylori-positive patients with nonulcer dyspepsia.
In confirmed peptic ulcer disease, between 88% and 100% of physicians would treat the H. pylori infection, depending on the physician group and whether or not the presentation of an ulcer was recurrent.
Although 103 distinct anti-H. pylori regimens were reported, 89% of the gastroenterologists and 70% of the primary care physicians (PCPs) used combinations of antimicrobials with reported cure rates of at least 80%. Conclusions : General knowledge regarding H. pylori-associated diseases was widespread among primary care physicians and gastroenterologists.
However, anti-H. (...)
Mots-clés Pascal : Bactériose, Infection, Helicobacter pylori, Spirillaceae, Spirillales, Bactérie, Gastrointestinal, Ulcère, Gastroduodénal, Pathogénie, Cofacteur, Connaissance, Médecin généraliste, Spécialité médicale, Résultat, Homme, Appareil digestif pathologie, Oesophage pathologie, Estomac pathologie, Intestin pathologie
Mots-clés Pascal anglais : Bacteriosis, Infection, Helicobacter pylori, Spirillaceae, Spirillales, Bacteria, Gastrointestinal, Ulcer, Gastroduodenal, Pathogenesis, Cofactor, Knowledge, General practitioner, Medical specialty, Result, Human, Digestive diseases, Esophageal disease, Gastric disease, Intestinal disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0248450
Code Inist : 002B30A01C. Création : 11/09/1998.